I25
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Regardless of sex, patients who were at least 18 years of age and hospitalized for their first elective CAG (coronary angiography) were eligible for the trial.
Exclusion criteria
Exclusion criteria: Patients with upper limb anomalies and those who underwent prior vascular interventions (TRA or TUA) were excluded. The additional exclusion criteria were as follows: RA or UA < 1.5 mm based on ultrasonography and positive Allen’s test results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful hemostasis without bleeding during hemostasis or after removal hemostatic device with no evidence of expanding forearm hematoma. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vascular complications, such as TAO (total artery occlusion), IPA (pseudoaneurysm) or large hematoma. | — |
Countries
Poland
Contacts
1Cardiology Department, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland